Rice University researchers used the Comet supercomputer at SDSC to evaluate their new molecular docking too to help improve cancer immunotherapy outcomes by identifying more effective personalized treatments.
Scientists, including UC San Diego researchers, recently relied on supercomputer simulations to better understand the reproductive mysteries of viruses and DNA.
The San Diego Supercomputer Center at UC San Diego has announced the launch of ‘HPC Share’, a data sharing resource that will enable users of the Center’s high-performance computing resources to easily transfer, share, and discuss their data within their research teams and beyond.
Researchers at the University of Rhode Island (URI) used the San Diego Supercomputer Center’s 'Comet' supercomputer to show that high-performance computer modeling can accurately simulate tsunamis from volcanic events.
Scientists work to understand circadian rhythms at the molecular level to help develop innovative therapies for fixing biological clock dysfunctions caused by inherited conditions, modern habits, shift working or aging.
SDSC and WIPAC researchers have conducted a second NSF-funded experiment that proves it is possible to elastically burst to very large scales of GPUs using the cloud.
The Protein Data Bank archive has released a new Coronavirus protease structure following the recent coronavirus outbreak, an ongoing viral epidemic primarily affecting mainland China that now threatens to spread to other parts of the world.
Researchers at Oregon State University have been using the Comet supercomputer at SDSC to test an algorithm they believe will reduce errors in the widely used three-day forecasts for water temperature, salinity levels, sea heights, and currents off the Oregon and Washington coasts.
A new study published late last year in the Monthly Notices of the Royal Astronomical Society used supercomputer simulations to explore molecular gas within and surrounding the intracluster medium, or the space between galaxies in a galaxy cluster.
A research team from SDSC and institutes in Sweden and France have published a study on the OLIG2 inhibitor as a way to improve prognoses for brain cancer patients.